| Literature DB >> 22275843 |
Alpaslan Yılmaz1, Fatma Simsek, Ali Saffet Gonul.
Abstract
Although it is known that individuals with schizophrenia demonstrate marked impairment in reinforcement learning, the details of this impairment are not known. The aim of this study was to test the hypothesis that reward-related probability learning is altered in schizophrenia patients. Twenty-five clinically stable schizophrenia patients and 25 age- and gender-matched controls participated in the study. A simple gambling paradigm was used in which five different cues were associated with different reward probabilities (50%, 67%, and 100%). Participants were asked to make their best guess about the reward probability of each cue. Compared with controls, patients had significant impairment in learning contingencies on the basis of reward-related feedback. The correlation analyses revealed that the impairment of patients partially correlated with the severity of negative symptoms as measured on the Positive and Negative Syndrome Scale but that it was not related to antipsychotic dose. In conclusion, the present study showed that the schizophrenia patients had impaired reward-based learning and that this was independent from their medication status.Entities:
Keywords: motivation; punishment; reinforcement learning; reward
Year: 2012 PMID: 22275843 PMCID: PMC3261650 DOI: 10.2147/NDT.S26243
Source DB: PubMed Journal: Neuropsychiatr Dis Treat ISSN: 1176-6328 Impact factor: 2.570
Clinical and demographic variables of patients and controls
| Variable | Schizophrenia patients (n = 25) | Controls (n = 25) | Comparison |
|---|---|---|---|
| Age (years) | 30.1 ± 8.4 | 30.8 ± 8.4 | |
| Gender (male/female) | 13/12 | 14/11 | χ2 = 0.1; df = 1; |
| Education (years) | 12.8 ± 2.8 | 14.2 ± 5.4 | |
| PANSS score | |||
| Positive | 12.3 ± 5.9 | NA | NA |
| Negative | 17.7 ± 10 | NA | NA |
| General psychopathology | 28.7 ± 13.5 | NA | NA |
| Total | 58.4 ± 27.3 | NA | NA |
| ESRS score | 5.9 ± 6 | NA | NA |
| Calgary Depression | 3.7 ± 4.9 | NA | NA |
| Scale score | |||
| Antipsychotic dose | 220.3 ± 129.3 | NA | NA |
| Total performance score | 36.6 ± 17.4 | 53.8 ± 11.7 | |
Notes: Chlorpromazine-equivalent dose (mg);
amount of money earned in the gambling task (TL).
Abbreviations: χ2,chi-square; df, degree of freedom; ESRS, Extrapyramidal Symptom Rating Scale; NA, not applicable; PANSS, Positive and Negative Syndrome Scale.
Figure 1Accuracy rates and reaction times of schizophrenia patients and controls.
Correlation matrix among clinical parameters with the total performance scores (amount of money earned in the gambling task) and the accuracy scores
| Clinical parameters | Total performance scores | Accuracy scores | ||
|---|---|---|---|---|
|
| ||||
| 50% | 67% | 100% | ||
| PANSS | ||||
| Positive | −0.042 | −0.05 | −0.051 | 0.018 |
| Negative | −0.03 | 0.17 | 0.171 | −0.38 |
| General psychopathology | −0.16 | 0.16 | −0.22 | −0.18 |
| Total | −0.24 | 0.13 | −0.193 | −0.23 |
| ESRS | −0.013 | 0.3 | −0.31 | −0.087 |
| Calgary | −0.088 | 0.25 | −0.14 | −0.12 |
| Depression Scale | ||||
| Antipsychotic dose | −0.122 | −0.13 | −0.14 | −0.51 |
Notes: P = 0.06;
Chlorpromazine-equivalent dose.
Abbreviations: ESRS, Extrapyramidal Symptom Rating Scale; PANSS, Positive and Negative Syndrome Scale.